Epidermal growth factor actions on arachidonic acid metabolism in human amnion cells.
Epidermal growth factor (EGF) from human and murine sources increased prostaglandin E2 production by human amnion cells. An anti-EGF receptor monoclonal antibody abolished this stimulatory action of EGF and reduced the basal rate of amnion prostaglandin E2 biosynthesis. The rates of formation of arachidonate lipoxygenase products were also enhanced by EGF.
D000650:Amnion / Q000187:drug effects* / Q000378:metabolism; D001091:Arachidonate Lipoxygenases / Q000378:metabolism; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism*; D002478:Cells, Cultured; D015232:Dinoprostone; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D066246:ErbB Receptors / Q000378:metabolism; D006801:Humans; D011458:Prostaglandins E / Q000096:biosynthesis
D001095:Arachidonic Acids; D011458:Prostaglandins E; D016718:Arachidonic Acid; D004815:Epidermal Growth Factor; D001091:Arachidonate Lipoxygenases; D066246:ErbB Receptors; D015232:Dinoprostone